Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

GSK and other Olympic sponsors may face hacking attack

IT security firm claims ‘hacktivist’ network Anonymous could target websites of London 2012 partners

GlaxoSmithKline could be targeted by 'hacktivist' network Anonymous, according to reports.

IT security firm Radware claims to have found evidence the hacking network, which earlier this year took down several UK government sites, is preparing to launch a denial-of-service attack on the pharma company's website.

Carl Herberger, vice president of security solutions at Radware, told Network World US that online posts indicate Anonymous could attack GSK and telecoms firm BT, both of whom are prominent sponsors of the London 2012 Games.

While there is, as expected, no way of verifying the information, which comes from someone claiming links with Anonymous, Herberger said some previous attacks have followed a similar pattern.

The potential threat emerged just over a year Bayer's Italian website was hit by 'illegal interference' by hackers affiliated with Anonymous in June, 2011.

Meanwhile, a separate UK group called The Script Kiddies took over Pfizer's Facebook page last July, defacing it and adding links to several articles critical of the pharma company.

1st August 2012

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
TBWA Paling Walters

We are a full-service integrated communications agency, specialising in healthcare.We are determined to find not only the right communication for...

Latest intelligence

The patient will see you now
GCI Health’s Laura Starr and Chris Bath report on how the dawning era of mobile tech and the ‘Internet of Things’ has transformed the health and wellness arena....
When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast...
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem....

Infographics